Free Trial

Jasper Hellweg Analyst Performance

Analyst at Argus

Jasper Hellweg is a stock analyst at Argus focused in the medical sector, covering 17 publicly traded companies. Over the past year, Jasper Hellweg has issued 2 stock ratings, including buy and hold recommendations. While full access to Jasper Hellweg's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Jasper Hellweg's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
28 Last 7 Years
Buy Recommendations
89.29% 25 Buy Ratings
Companies Covered
17 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy89.3%25 ratings
Hold10.7%3 ratings
Sell0.0%0 ratings

Out of 28 total stock ratings issued by Jasper Hellweg at Argus, the majority (89.3%) have been Buy recommendations, followed by 10.7% Hold.

Exchange Coverage

ExchangePercentageCount
NYSE
52.9% of companies on NYSE
9 companies
NASDAQ
47.1% of companies on NASDAQ
8 companies

Jasper Hellweg, an analyst at Argus, currently covers 17 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Medical
15 companies
88.2%
Computer and Technology
1 company
5.9%
Business Services
1 company
5.9%

Jasper Hellweg of Argus specializes in stock coverage within the Medical sector, with additional focus on Computer and Technology and Business Services companies.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
7 companies
41.2%
PHARMACEUTICAL PREPARATIONS
2 companies
11.8%
MED - DRUGS
1 company
5.9%
MEDICAL SERVICES
1 company
5.9%
INTERNET SOFTWARE
1 company
5.9%
MED PRODUCTS
1 company
5.9%
MED - OUTP/HM CRE
1 company
5.9%
FINANCIAL TRANSACTION SERVICES
1 company
5.9%
MED INSTRUMENTS
1 company
5.9%
MED - HOSPITALS
1 company
5.9%

Jasper Hellweg's Ratings History at Argus

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Zoetis Inc. stock logo
ZTS
Zoetis
9/9/2025Reiterated Rating$151.26$190.00Buy
Biogen Inc. stock logo
BIIB
Biogen
4/4/2025Downgrade$130.71Hold